OncoSec Medical Collaborates with PerkinElmer and University of California, Los Angeles to Evaluate Patient-Selection ...

OncoSec Medical Inc. , a company developing DNA-based intratumoral cancer immunotherapies, announced a collaboration with PerkinElmer, Inc. and the University of California, Los Angeles to help researchers develop biomarker tests to evaluate a patient’s immune response to cancer.



from Content Keyword RSS http://ift.tt/1tHv0QE

via IFTTT